Facebook Pixel Code

Cipla Share Price

NSE
BSE
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Cipla Price Performance

Today's LowToday's High
₹1,320.95₹1,337.50
₹1,334.00
52 Weeks' Low52 Weeks' High
₹1,165.55₹1,672.20
₹1,334.00
Open Price
₹1,328.95
Prev. Close
₹1,346.85
Volume
33,440

Source: Dion Global

Cipla Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Cipla
-4.52-5.60-8.3911.78-11.984.106.84
Sun Pharmaceutical Industries
-3.86-7.81-4.785.159.0515.9916.46
Divi's Laboratories
-4.13-0.2138.0457.3057.0335.2812.03
Torrent Pharmaceuticals
-4.61-4.981.9819.2035.3236.2424.92
Zydus Lifesciences
-5.28-1.103.5331.7315.1523.0915.15
Laurus Labs
-1.855.4228.7788.09126.6770.3425.88
Mankind Pharma
0.184.20-0.3024.161.2611.2911.73
Dr. Reddy's Laboratories
0.434.05-10.27-0.79-3.213.423.67
Aurobindo Pharma
-2.410.837.0525.0052.7122.5117.93
Lupin
-3.83-6.62-16.20-11.721.9319.6515.89
Glenmark Pharmaceuticals
-4.26-6.943.958.9415.3039.3734.43
Alkem Laboratories
-1.61-0.48-5.66-1.37-4.5913.225.49
Biocon
-2.95-7.86-11.734.885.0110.700.27
Abbott India
-2.181.242.440.28-12.014.532.63
Ipca Laboratories
-2.04-1.3812.2829.8446.9527.309.94
Gland Pharma
0.051.8119.2872.6149.3920.02-5.49
Anthem Biosciences
-2.76-8.9510.2428.5911.995.203.09
GlaxoSmithKline Pharmaceuticals
-2.93-7.2113.1718.34-0.0320.3012.77
Ajanta Pharma
-1.770.144.2524.7145.0824.8917.85
Emcure Pharmaceuticals
-0.424.294.4525.1144.5212.547.35

Source: Dion Global

Over the last one year, Cipla has declined 11.98% compared to peers like Sun Pharmaceutical Industries (9.05%), Divi's Laboratories (57.03%), Torrent Pharmaceuticals (35.32%). From a 5 year perspective, Cipla has underperformed peers relative to Sun Pharmaceutical Industries (16.46%) and Divi's Laboratories (12.03%).

Cipla Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Cipla Stock Technicals

Moving Average

DaySMAEMA
51,373.191,365.62
101,378.741,373.46
201,377.371,382.6
501,414.391,398.86
1001,412.561,399.53
2001,380.481,406.34

Source: Dion Global

Cipla Share Holding Pattern

In the latest quarter, Cipla remained same as its previous close in promoter holding, while DII stake increased to 34.63%, FII holding fell to 20.20%, and public shareholding moved down to 15.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Cipla Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
1,99,02,4292.472,804.65
1,43,51,6291.372,022.43
55,49,3731.3782.02
47,56,6372.11670.31
47,33,2072.37667
40,95,0546.09577.08
40,86,2111.06575.83
38,36,9851.14540.71
35,00,0000.87493.22
28,57,9465.76402.74

Source: Dion Global

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Cipla Corporate Actions

Date Time
Announcement
Sep 29, 2026, 12:45 AM IST ISTCipla - Board Meeting Intimation for The Quarter And Half Year Ended 30Th September, 2026 Under SEBI (Listing Obligations And
Sep 25, 2026, 12:38 AM IST ISTCipla - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Sep 23, 2026, 04:26 AM IST ISTCipla - Announcement under Regulation 30 (LODR)-Change in Management
Sep 18, 2026, 11:03 PM IST ISTCipla - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) R
Sep 04, 2026, 01:36 AM IST ISTCipla - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source: Dion Global

About Cipla

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 18979.95 Cr. and Equity Capital is Rs. 161.56 Cr. for the Year ended 31/03/2026.

Source: Dion Global

Management

  • Dr. Y K Hamied
    Chairman
  • Mr. P R Ramesh
    Vice Chairman & Independent Director
  • Mr. Achin Gupta
    Managing Director & Global CEO
  • Mr. Abhijit Joshi
    Non Executive Director
  • Mr. Adil Zainulbhai
    Non Executive Director
  • Mr. Kamil Hamied
    Non Executive Director
  • Ms. Maya Hari
    Independent Director
  • Dr. Balram Bhargava
    Independent Director
  • Dr. Mandar Vaidya
    Independent Director
  • Ms. Sharmila Paranjpe
    Independent Director

FAQs on Cipla Share Price

What is the share price of Cipla?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cipla is ₹1,334.00 as on Oct 05, 2026.

What kind of stock is Cipla?

The Cipla is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.

What is the Market Cap of Cipla?

The market cap of Cipla is ₹107,769.94 Cr as on Oct 05, 2026.

What are today's High and Low prices of Cipla?

Today’s highest and lowest price of Cipla are ₹1,337.50 and ₹1,320.95.

What are the 52 Week High and 52 Week Low of Cipla?

The 52-week high/low is the highest and lowest price at which Cipla stock has traded in the past 52-week or nearly a year. The 52-week high of Cipla is ₹1,672.20 and 52-week low of Cipla is ₹1,165.55 as on Oct 05, 2026.

How has the Cipla performed historically in terms of returns?

The Cipla has shown returns of -0.95% over the past day, -5.6% for the past month, -8.39% over 3 months, -11.98% over 1 year, 4.1% across 3 years, and 6.84% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Cipla?

P/E ratio of and PB ratio of Cipla are 31.97 and 3.06 on Oct 05, 2026. While the company gives a dividend yield of 0.97 per annum.

Source: Dion Global